Andrew Pardoll

Alıntı yapanlar

	Hepsi	2020 yılından bugüne
Alıntılar	195109	79021
h-endeksi	178	114
i10-endeksi	477	331

18000

9000

4500

13500

1989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025543 527 607 588 700 821 935 1034 1127 1272 1431 1630 1658 1803 2051 2015 2243 2256 2367 2552 2308 2815 3036 3643 5505 6404 8626 11508 12847 13802 14486 15820 17812 15961 14301 12986 2116

Genel erişim

Tümünü görüntüle

220 makale

8 makale

genel erişime açık olanlar

genel erişime açık olmayanlar

Finansman sağlayan kuruluşun getirdiği zorunluluğa dayalı olarak

Katkıda bulunan yazarlar

Elizabeth JaffeeJohns Hopkins University School of Medicinejhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Hy LevitskyProfessor of Oncology, Medicine, Urologyjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Franck HousseauJohns Hopkins Universityjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Charles G. DrakeImmunologyjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Robert A. AndersJohns Hopkinsjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Lieping ChenYale Universityyale.edu üzerinde doğrulanmış e-posta adresine sahip
Bert VogelsteinJohns Hopkinsjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Tzyy-Choou (T.-C.) WuJohns Hopkins University School of Medicinejhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Henry BremHarvey Cushing Professor, Chairman Dept of Neurosurgery, Johns Hopkins School of Medicinejhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Yen Hung-Rong (顏宏融)School of Chinese Medicine, China Medical University, Taichung, Taiwanmail.cmu.edu.tw üzerinde doğrulanmış e-posta adresine sahip
Evan J. LipsonAssociate Professor of Oncology, Johns Hopkins Universityjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Marcin KortylewskiProfessor, Beckman Research Institute at City of Hope, CAcoh.org üzerinde doğrulanmış e-posta adresine sahip
Christopher JacksonJohns Hopkins Universityjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Alex Y. HuangCase Western Reserve University School of Medicine / UH Rainbow Babies & Children's Hospitalcase.edu üzerinde doğrulanmış e-posta adresine sahip
Dimitris MathiosAssistant Professor of Neurosurgery, Washington University in St Louiswustl.edu üzerinde doğrulanmış e-posta adresine sahip
Dario VignaliUniversity of Pittsburghpitt.edu üzerinde doğrulanmış e-posta adresine sahip
Kevin GorskiAmgen, Inc.amgen.com üzerinde doğrulanmış e-posta adresine sahip
Richard SchulickProfessor and Chair of Department of Surgery and Cancer Center Director, University of Coloradoucdenver.edu üzerinde doğrulanmış e-posta adresine sahip
Chien-Fu HungJohns Hopkins Universityjhmi.edu üzerinde doğrulanmış e-posta adresine sahip
Andrea CoxProfessor of Medicine, Johns Hopkins Universityjhmi.edu üzerinde doğrulanmış e-posta adresine sahip

Takip et

Andrew Pardoll

Johns Hopkins University school of medicine

jhmi.edu üzerinde doğrulanmış e-posta adresine sahip

immunology cancer immunotheapy


Başlık Alıntılara göre sırala Yıla göre sırala Başlığa göre sırala	Alıntı yapanlar Alıntı yapanlar	Yıl
The blockade of immune checkpoints in cancer immunotherapy DM Pardoll Nature reviews cancer 12 (4), 252-264, 2012	15479	2012
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer SL Topalian, FS Hodi, JR Brahmer, SN Gettinger, DC Smith, ... New England Journal of Medicine 366 (26), 2443-2454, 2012	14374	2012
PD-1 blockade in tumors with mismatch-repair deficiency DT Le, JN Uram, H Wang, BR Bartlett, H Kemberling, AD Eyring, ... New England Journal of Medicine 372 (26), 2509-2520, 2015	10178	2015
Safety and activity of anti–PD-L1 antibody in patients with advanced cancer JR Brahmer, SS Tykodi, LQM Chow, WJ Hwu, SL Topalian, P Hwu, ... New England journal of medicine 366 (26), 2455-2465, 2012	9194	2012
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade DT Le, JN Durham, KN Smith, H Wang, BR Bartlett, LK Aulakh, S Lu, ... Science 357 (6349), 409-413, 2017	6602	2017
STATs in cancer inflammation and immunity: a leading role for STAT3 H Yu, D Pardoll, R Jove Nature reviews cancer 9 (11), 798-809, 2009	4835	2009
Immune checkpoint blockade: a common denominator approach to cancer therapy SL Topalian, CG Drake, DM Pardoll Cancer cell 27 (4), 450-461, 2015	4342	2015
Phase I study of single-agent anti–programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates JR Brahmer, CG Drake, I Wollner, JD Powderly, J Picus, WH Sharfman, ... Journal of clinical oncology 28 (19), 3167-3175, 2010	3698	2010
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor … G Dranoff, E Jaffee, A Lazenby, P Golumbek, H Levitsky, K Brose, ... Proceedings of the National Academy of Sciences 90 (8), 3539-3543, 1993	3445	1993
Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab SL Topalian, M Sznol, DF McDermott, HM Kluger, RD Carvajal, ... Journal of clinical oncology 32 (10), 1020-1030, 2014	2776	2014
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy SL Topalian, JM Taube, RA Anders, DM Pardoll Nature Reviews Cancer 16 (5), 275-287, 2016	2739	2016
Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti–PD-1 therapy JM Taube, A Klein, JR Brahmer, H Xu, X Pan, JH Kim, L Chen, DM Pardoll, ... Clinical cancer research 20 (19), 5064-5074, 2014	2626	2014
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape JM Taube, RA Anders, GD Young, H Xu, R Sharma, TL McMiller, S Chen, ... Science translational medicine 4 (127), 127ra37-127ra37, 2012	2472	2012
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment H Yu, M Kortylewski, D Pardoll Nature reviews immunology 7 (1), 41-51, 2007	2208	2007
Neoadjuvant PD-1 blockade in resectable lung cancer PM Forde, JE Chaft, KN Smith, V Anagnostou, TR Cottrell, MD Hellmann, ... New England Journal of Medicine 378 (21), 1976-1986, 2018	2109	2018
Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses KB Chiappinelli, PL Strissel, A Desrichard, H Li, C Henke, B Akman, ... Cell 162 (5), 974-986, 2015	1931	2015
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses S Wu, KJ Rhee, E Albesiano, S Rabizadeh, X Wu, HR Yen, DL Huso, ... Nature medicine 15 (9), 1016-1022, 2009	1884	2009
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape SR Woo, ME Turnis, MV Goldberg, J Bankoti, M Selby, CJ Nirschl, ... Cancer research 72 (4), 917-927, 2012	1867	2012
Control of TH17/Treg balance by hypoxia-inducible factor 1 EV Dang, J Barbi, HY Yang, D Jinasena, H Yu, Y Zheng, Z Bordman, J Fu, ... Cell 146 (5), 772-784, 2011	1736	2011
The central role of CD4+ T cells in the antitumor immune response K Hung, R Hayashi, A Lafond-Walker, C Lowenstein, D Pardoll, ... Journal of Experimental Medicine 188 (12), 2357-2368, 1998	1726	1998

Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.

Makaleler 1–20

Yıllık alıntı sayısı

Mükerrer alıntılar

Birleştirilmiş alıntılar

Katkıda bulunan yazar ekleKatkıda bulunan yazarlar

Takip et

Alıntı yapanlar

Katkıda bulunan yazarlar